Delivery Order SPE2DR25D6028-SPE2DR26FARGB
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on October 28, 2025, for the supply of Ketorolac 30 mg/ml vials under a firm fixed-price contract with a ceiling value of $2,397.44. This non-set-aside competitive award is funded by the Defense Logistics Agency's Medical Supply Chain division and will be performed at the contractor's Conshohocken facility, with an ultimate completion date of October 29, 2025....
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Ketorolac 30 mg/mL vials with a ceiling value of $1,002.57. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 12, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ketorolac 30 mg/mL vials with a ceiling value of $1,858.48. The contract was awarded on September 19, 2025, with an ultimate completion date of September 22, 2025, and utilized firm fixed-price pricing without any set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its...
- AmerisourceBergen Drug Corp was awarded a $6,158.11 firm fixed price delivery order by the Defense Logistics Agency's Medical Supply Chain on August 15, 2025, for the supply of Ketorolac 30 mg/mL vials. The contract, which is non-set-aside and competitively awarded, is scheduled for completion by August 18, 2025, with performance taking place at the vendor's Conshohocken, Pennsylvania facility. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Ketorolac 30 mg/mL in vial form, with a ceiling value of $1,339.14. This is a firm fixed price delivery order issued under a competitive, non-set-aside procurement. The order is scheduled for ultimate completion on September 19, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a $1,163.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ketorolac 30 mg/mL vials on November 3, 2025, with completion scheduled for November 4, 2025. This contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, is...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency for the supply of Ketorolac 30 mg/ml vials. The contract, issued on August 8, 2025, carries a ceiling value of $1,279.84 and is structured as a firm fixed-price delivery order with an ultimate completion date of August 11, 2025. The place of performance is the contractor's corporate office in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation. This delivery...
- On September 15, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,022.86 to AmerisourceBergen Drug Corp for the supply of Ketorolac 30 mg/ml vials. This competitively awarded, firm fixed-price delivery order is set to be completed by September 16, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Ketorolac 30 mg/mL vials with a ceiling value of $1,858.48. This is a firm fixed-price delivery order issued under a competitive, non-set-aside procurement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 26, 2025. This delivery order...
- The Defense Logistics Agency has awarded a delivery order valued at $2,909.40 to AmerisourceBergen Drug Corp for the supply of Ketorolac 30 mg/mL vials. This competitive award, issued on August 19, 2025, represents a firm fixed price delivery order with an ultimate completion date of August 20, 2025. The pharmaceutical distributor will fulfill this order from its corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen Drug Corp's larger...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FARGBDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on November 3, 2025, for the supply of Ketorolac 60mg/2ml in quantities of 25 units. This firm fixed-price delivery order, valued at $8,163.57, represents a non-competitive award and is scheduled for completion by December 2, 2025. The contract will be performed at AmerisourceBergen's Conshohocken facility and supports the federal government's pharmaceutical procurement needs for military and defense healthcare operations. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999 and extends through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard. The current delivery order for Ketorolac, a nonsteroidal anti-inflammatory pain management pharmaceutical, exemplifies the company's role in fulfilling critical medical supply requirements across the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.2k | 11/3/25 |